Kantar Hires Pharma Veteran to Lead Oncology Team

In New York, Kantar Health has appointed Debbie Warner as Vice President in charge of its Oncology Commercial Strategies team, which provides information and analysis on the influence of sector stakeholders.

Warner joins with more than twenty years' experience in the pharmaceutical industry. She began her career with Merck in 1988, and has since held senior positions with Astra Merck and AstraZeneca, including field sales, national accounts, brand management, medical affairs and managed markets strategy. Most recently, she used her commercial and clinical experience and understanding of payer perspectives as Managed Markets Brand Director, Specialty Care Oncology Growth Brands.

In her new role in the Commercial Planning group, Warner will oversee a team which works directly with clients on custom engagements to optimize their oncology commercialization strategies. This team also manages Kantar Health's Oncology Market Access US, which provides clients with information to help commercialize cancer drugs.

Commenting on Warner's appointment, Patricia Ensor, SVP of Kantar Health, said: 'Debbie's commercial development experience in the pharmaceutical industry will give our clients the benefit of insightful analysis and actionable recommendations as they compete in an increasingly challenging oncology market. Her background enhances our vast global oncology offer, which combines custom consulting and multi-client subscriptions'.

Web site: www.kantarhealth.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Kantar Health
• All news